Imeglimin prevents heart failure with preserved ejection fraction by recovering the impaired unfolded protein response in mice subjected to cardiometabolic stress-Reference-Cited by-同舟云学术

Imeglimin prevents heart failure with preserved ejection fraction by recovering the impaired unfolded protein response in mice subjected to cardiometabolic stress

Published:2021-10 Issue: Volume:572 Page:185-190
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Kitakata Hiroki,Endo Jin,Hashimoto Shun,Mizuno Erika,Moriyama Hidenori,Shirakawa Kohsuke,Goto Shinichi^ORCID,Katsumata Yoshinori,Fukuda Keiichi^ORCID,Sano Motoaki^ORCID

Funder

Japan Society for the Promotion of Science

Keio University

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference37 articles.

1. Type 2 diabetes mellitus and heart failure: a scientific statement from the American heart association and the heart failure society of America: this statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update;Dunlay;Circulation,2019

2. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) programme;MacDonald;Eur. Heart J.,2008

3. Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction

4. Nitrosative stress drives heart failure with preserved ejection fraction;Schiattarella;Nature,2019

5. Xbp1s-FoxO1 axis governs lipid accumulation and contractile performance in heart failure with preserved ejection fraction;Schiattarella;Nat. Commun.,2021

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of ferroptosis in the pathogenesis of heart disease;Frontiers in Physiology;2024-09-10

2. Novel Therapeutics for Type 2 Diabetes Mellitus—A Look at the Past Decade and a Glimpse into the Future;Biomedicines;2024-06-21

3. Exploring new mechanisms of Imeglimin in diabetes treatment: Amelioration of mitochondrial dysfunction;Biomedicine & Pharmacotherapy;2024-06

4. Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future;Cell Biology and Toxicology;2024-03-21

5. Metabolic dysfunction induced by HFD + L-NAME preferentially affects hippocampal mitochondria, impacting spatial memory in rats;Journal of Bioenergetics and Biomembranes;2024-02-20